AmeriWater Signs Agreement with Vizient to Expand Access to ST108-Compliant Water Solutions

AmeriWater, a leading provider of advanced water purification systems for healthcare, is pleased to announce it has signed an agreement with Vizient®...

August 29, 2025 | Friday | News
Wugen Secures $115 Million Financing to Advance Pivotal Trial of First-in-Class Allogeneic CAR-T Therapy

Financing led by Fidelity Management & Research Company with participation from RiverVest Venture Partners, Lightchain Capital, LYZZ Capital, Abingw...

August 28, 2025 | Thursday | News
Evoke Pharma Expands GIMOTI® Access Through Omnicell and Specialty Pharmacy Partnerships

Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on developing treatments for gastrointestinal (GI) diseases, with a pa...

August 27, 2025 | Wednesday | News
Scenic Biotech Enters Research Collaboration with Alnylam to Discover Novel RNAi Targets Using Cell-Seq Platform

Scenic Biotech, a pioneer in modifier therapies for severe diseases, announced a license and research agreement with Alnylam Pharmaceuticals, Inc. (NASDA...

August 27, 2025 | Wednesday | News
Piramal Pharma Solutions Opens Dedicated OSD Suite in U.S. to Support NewAmsterdam Pharma’s Cholesterol Therapy

The multi-million-dollar investment provides NewAmsterdam Pharma with commercial capacity for fixed dose combination (FDC) of obicetrapib and ezetimibe...

August 25, 2025 | Monday | News
Alvotech and Advanz Pharma Secure European Commission Approval for Mynzepli®, a Biosimilar to Eylea®

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Adva...

August 22, 2025 | Friday | News
Agilent MMR IHC Panel pharmDx Wins FDA Approval as Companion Diagnostic for Colorectal Cancer

-Agilent Technologies Inc. announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for ...

August 21, 2025 | Thursday | News
BioSkryb Genomics Secures Exclusive License for Stanford and CZ Biohub SF Innovation in Single-Cell Methylation and Variant Analysis

The licensed IP enables genome-wide methylation and variant analyses in the same single cells or ultra-low input samples BioSkryb Genomics, a ...

August 21, 2025 | Thursday | News
Invivyd Secures FDA Alignment on Single Phase 2/3 Trial Pathway for VYD2311 COVID-19 Prevention BLA

Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, doubl...

August 15, 2025 | Friday | News
CILA Therapeutics Secures NIH Grant to Advance CIL-Key™ Platform for Inhaled RNA Delivery in Lung Diseases

-CILA Therapeutics has been awarded a competitive grant from the National Center for Advancing Translational Sciences (NCATS), part of the National Insti...

August 15, 2025 | Friday | News
Cytiva and Culture Biosciences Partner to Deliver Seamless Scale-Up with Stratyx 250 Bioreactor

  Cytiva has deepened its partnership with Culture Biosciences, introducing the Stratyx 250 process development bioreactor. Speaking to BioPharma Boa...

August 18, 2025 | Monday | News
Sarepta Advances SRP-1003 for DM1 Triggering $100 Million Milestone Payment to Arrowhead

Safety review leading to dose escalation and achievement of first predetermined enrollment target in Phase 1/2 study of SRP-1003 for DM1 triggers $100 ...

August 14, 2025 | Thursday | News
Amalgam Secures $20M Credit Investment from Catalio Capital to Accelerate Medical-Grade AI Expansion

 announced a $20 million credit investment from Catalio Capital Management, a leading investment firm dedicated to backing innovative healthcare com...

August 13, 2025 | Wednesday | News
Fosun Pharma Grants Global Rights (Ex-China) for Innovative Respiratory Drug XH-S004 to Expedition Therapeutics

Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics ...

August 12, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close